These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 36967117

  • 1. Efficacy of generic forms of itraconazole capsule in treating subjects with chronic pulmonary aspergillosis.
    Sehgal IS, Vinay K, Dhooria S, Muthu V, Prasad KT, Aggarwal AN, Chakrabarti A, Rudramurthy SM, Choudhary H, Agarwal R.
    Mycoses; 2023 Jul; 66(7):576-584. PubMed ID: 36967117
    [Abstract] [Full Text] [Related]

  • 2. Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
    Sehgal IS, Dhooria S, Prasad KT, Muthu V, Aggarwal AN, Chakrabarti A, Agarwal R.
    Mycoses; 2021 Sep; 64(9):1053-1061. PubMed ID: 34031920
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis.
    Jhun BW, Jeon K, Eom JS, Lee JH, Suh GY, Kwon OJ, Koh WJ.
    Med Mycol; 2013 Nov; 51(8):811-7. PubMed ID: 23834282
    [Abstract] [Full Text] [Related]

  • 4. Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers.
    Sehgal IS, Dhooria S, Choudhary H, Aggarwal AN, Garg M, Chakrabarti A, Agarwal R.
    Clin Microbiol Infect; 2019 Sep; 25(9):1157.e1-1157.e7. PubMed ID: 30685498
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H, Kaneda T, Kida Y, Kaneko M, Fujii H, Hayashi M, Tomii K, Tada K, Suzuki Y, Karino T.
    Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
    [Abstract] [Full Text] [Related]

  • 8. Itraconazole Serum Trough Concentrations Using Oral Capsules for the Treatment of Chronic Pulmonary Aspergillosis: What is the Target?
    de Oliveira VF, Taborda M, Arcieri VC, Kruschewsky WLL, Costa AN, Duarte NJC, Romano P, de Almeida Rezende Ebner P, Magri ASGK, Abdala E, Levin AS, Magri MMC.
    Mycopathologia; 2023 Oct; 188(5):693-698. PubMed ID: 37526790
    [Abstract] [Full Text] [Related]

  • 9. Impact of treatment duration on recurrence of chronic pulmonary aspergillosis.
    Im Y, Jhun BW, Kang ES, Koh WJ, Jeon K.
    J Infect; 2021 Oct; 83(4):490-495. PubMed ID: 34332020
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
    Yasuda S, Ohnishi R, Suzuki T, Sano K, Kato T.
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):985-90. PubMed ID: 19994592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
    Saito W, Shishikura Y, Nishimaki K, Kikuchi T, Sasamori K, Kikuchi Y, Miki H.
    Kansenshogaku Zasshi; 2014 Jul; 88(4):469-73. PubMed ID: 25199382
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beads and Beyond: An Observational Study to Generate Real World Evidence on Various Brands of Itraconazole.
    Kar D, Das A.
    Indian J Dermatol; 2022 Jul; 67(4):399-403. PubMed ID: 36578764
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.